- Home
- APVO vs SANW Comparison
APVO vs SANW Comparison
Compare APVO & SANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- SANW
- Stock Information
- Founded
- APVO 2016
- SANW 1980
- Country
- APVO United States
- SANW United States
- Employees
- APVO N/A
- SANW N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- SANW Farming/Seeds/Milling
- Sector
- APVO Health Care
- SANW Consumer Staples
- Exchange
- APVO Nasdaq
- SANW Nasdaq
- Market Cap
- APVO 4.1M
- SANW 4.6M
- IPO Year
- APVO N/A
- SANW 2010
- Fundamental
- Price
- APVO $3.06
- SANW $1.77
- Analyst Decision
- APVO Strong Buy
- SANW Strong Buy
- Analyst Count
- APVO 1
- SANW 1
- Target Price
- APVO $5,920.00
- SANW $25.00
- AVG Volume (30 Days)
- APVO 191.0K
- SANW 100.5K
- Earning Date
- APVO 08-07-2025
- SANW 05-15-2025
- Dividend Yield
- APVO N/A
- SANW N/A
- EPS Growth
- APVO N/A
- SANW N/A
- EPS
- APVO N/A
- SANW N/A
- Revenue
- APVO N/A
- SANW $54,993,808.00
- Revenue This Year
- APVO N/A
- SANW N/A
- Revenue Next Year
- APVO N/A
- SANW $17.19
- P/E Ratio
- APVO N/A
- SANW N/A
- Revenue Growth
- APVO N/A
- SANW 6.91
- 52 Week Low
- APVO $2.81
- SANW $1.50
- 52 Week High
- APVO $381.10
- SANW $11.60
- Technical
- Relative Strength Index (RSI)
- APVO 38.28
- SANW 31.84
- Support Level
- APVO $3.01
- SANW $1.50
- Resistance Level
- APVO $3.18
- SANW $2.15
- Average True Range (ATR)
- APVO 0.16
- SANW 0.23
- MACD
- APVO 0.19
- SANW 0.10
- Stochastic Oscillator
- APVO 45.45
- SANW 25.00
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.